LABNOVATION TECHNOLOGIES, INC.
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
Explore comprehensive manufacturer profile for LABNOVATION TECHNOLOGIES, INC. based in China through Pure Global AI's free Brazil medical device database. This manufacturer has 10 products registered with ANVISA across 3 unique technical categories. Their regulatory history spans from Jun 24, 2021 to Jan 02, 2024.
This page provides detailed insights including 5 recent product registrations including GLYCATED HEMOGLOBIN (HbA1C), 3 most popular products with LYSIS SOLUTION having 6 registrations, 3 registration holders including Vida Biotecnologia Ltda - ME, and 5 key competitors with SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD sharing 3 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.